All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervical Neoplasms-15929080
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 15929080 A61G
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
2 15929080 H24Y
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
3 15929080 H78Y
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
4 15929080 K11T
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
5 15929080 K68R
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
6 15929080 L12V
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
7 15929080 L83V
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
8 15929080 P13L
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
9 15929080 Q14D
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
10 15929080 Q14H
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
11 15929080 R10G
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
12 15929080 R10I
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
13 15929080 R10T
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
14 15929080 T17C
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
15 15929080 T21S
E6
E6
Uterine Cervical Neoplasms
G
C
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.